胸腺肽辅助治疗初治涂阳继发型肺结核化疗的疗效  

Study the immunefunction of thymopetidum on the assistant trentment of the untreated smear - positive pulnmary tubueclosis

作　　者：张春晓[1] 张会强 

机构地区：[1]河南省新乡医学院第一附属医院结核内三科,453100

出　　处：《医学信息（下旬刊）》2010年第2期13-14,共2页Medical information

摘　　要：目的：观察胸腺肽辅助治疗初治涂阳Ⅲ型肺结核化疗的疗效。方法：将160例初治涂阳继发型肺结核患者随机分为治疗组（2HRZE／6HR＋胸腺肽80mg静滴，每日1次，连用2月，80例）和对照组（2HRZE／6HR，80例）。结果：抗痨强化治疗2个月末时，两组在临床症状、痰茵阴转及肺部病灶吸收率等方面均有显著性差异。结论：胸腺肽辅助治疗继发型肺结核，可较快改善临床症状。明显缩短痰结核菌转阴的时间，加快肺部病灶的吸收速。Aim To study the immune function of thymopetidum on the assistant treatment of the untreated smear- positive pulmnary tubueclosisⅢ. Methods 160 cases of the untreated smear -positive pulmnary tubucclosis Ⅲ randomly divided into groups： treatmentgroup（ n = 80） ,which be treated with 2 HRZE/4 HR and 80mg thymopetium one time everyday during the first two months and controlgroup（ n = 80） which be only treated with 2HRZE/6HR. Results when the end of anti - tuberculosis intensive therapy （ 2 months）, there were significant differences in the rate of symptoms,conversion and absorption between treatment and control group. Conclusions theymopetidum, which play the assistant treatment of PT Ⅲ, can rapidly improve the clinical symptoms, significantly shorten the time of negativing the TB and accelerate the velocity of absorption by the diseased lung.

关 键 词：抗痨 胸腺肽 继发型肺结核 

分 类 号：R521[医药卫生—内科学]